Image source: Unsplash/Rodion Kutsaev

Heart failure monitoring

App detects fluid in the lungs via voice recordings

Voice analysis by a smartphone app identifies lung congestion in heart failure patients, allowing early intervention before their condition deteriorates.

The small study is presented on HFA Discoveries, a scientific platform of the European Society of Cardiology (ESC). “Speech is personal and as such, very small changes (related to the same person) can be detected – for example, the ability of parents to notice health issues by listening to their kids,” said study author Professor Offer Amir, director of the Heart Institute, Hadassah Medical Centre, Jerusalem, Israel. “Today we report results of the first easy to use, non-invasive, personalised heart failure monitoring device. It requires a simple 30-second recording each day, in any language.”

Recommended article

Photo

Corona-induced coughing

New app listens to the 'sounds of COVID-19'

A new app, which will be used to collect data to develop machine learning algorithms that could automatically detect whether a person is suffering from COVID-19 based on the sound of their voice, their breathing and coughing, has been launched by researchers at the University of Cambridge. The COVID-19 Sounds App is now available as a web app for Chrome and Firefox browsers. Versions for Android…

Heart failure is one of the leading causes of morbidity and mortality, affecting more than 26 million people worldwide, and is the leading cause of hospitalisation in the US and Europe. Tight surveillance of patients could reduce related hospitalisations and deaths. In patients with heart failure, the pumping function of the heart is not working as it should. The most common symptom is shortness of breath, which is caused by water congestion in the lungs. Congestion can be life-threatening and early identification is crucial.

Lung congestion causes subtle changes in speech patterns, which may be a tool for assessing clinical status. Speech processing is currently used in a number of ways, for example converting text to speech and automatic voice recognition. This study examined the ability of a novel mobile application called Cordio HearO to distinguish between congested and non-congested states. The study included 40 patients admitted to hospital with acute heart failure and lung congestion. Patients were asked to record five sentences into a standard smartphone upon admission and then again just prior to discharge when they were no longer congested. The duration of each recording was 2-5 seconds. The researchers found that the technology successfully distinguished between the congested state at admission and the non-congested state at discharge.

Those with early signs of lung congestion could receive adjustments to their treatment, thereby preventing the need for hospitalisation

Offer Amir

Professor Amir said the system could be used to monitor heart failure patients at home. Physicians prescribe the app, patients download it to their smartphone and submit voice recordings when they feel well so the app can create a personalised “healthy” model. Each day patients add a recording, which the app compares to the healthy model. Small deviations denoting the start of fluid accumulation generate an alert, which physicians pick up from a designated web portal. “Those with early signs of lung congestion could receive adjustments to their treatment, thereby preventing the need for hospitalisation,” said Professor Amir. “As more speech samples are obtained, the model becomes increasingly sensitive to changes.” He added: “During the current COVID-19 pandemic healthcare professionals are transitioning many outpatient visits for heart failure patients to telemedicine platforms, highlighting the importance of remote monitoring to reduce the risk of exposure to coronavirus.”


Source: European Society of Cardiology (ESC)

22.06.2020

Read all latest stories

Related articles

Photo

Remote cardiology

A real-time telemonitoring device for heart failure patients

Medical monitoring tech company Umana Medical announced a collaboration with the Preventive Cardiology and Medical Prevention, Center of Cardiology at the University Medical Center Mainz and Bayer AG…

Photo

Cardiovascular disease prevention

An ultrasound sensor to measure pulse wave velocity and blood pressure

Nanoelectronics and digital technologies company Imec presents a proof-of-concept for determining arterial stiffness, a risk marker for cardiovascular diseases such as stroke and heart failure, and…

Photo

Cardiac care to go

Wearables in cardiology: from activity monitoring to research support

Activity monitors on phones and bracelets are helping assess exercise performance but experts say it remains unclear which are most suitable for research or best at motivating cardiovascular patients…

Related products

Lifotronic - FA-160 Immunofluorescence Analyzer

Other

Lifotronic - FA-160 Immunofluorescence Analyzer

Lifotronic Technology Co., Ltd
Alsachim, a Shimadzu group company – Dosinaco

Clinical Chemistry

Alsachim, a Shimadzu group company – Dosinaco

Alsachim, a Shimadzu Group Company
Siemens Healthineers - teamplay myCare Companion

Business Intelligence

Siemens Healthineers - teamplay myCare Companion

Siemens Healthineers
SIUI · Apogee 6500 Color Doppler Ultrasound Imaging System

Artificial Intelligence

SIUI · Apogee 6500 Color Doppler Ultrasound Imaging System

Shantou Institute of Ultrasonic Instruments Co., Ltd. (SIUI)
Ziehm – Vision R

Surgical II-C-Arms

Ziehm – Vision R

Ziehm Imaging GmbH
Subscribe to Newsletter